Fludarabine, Bortezomib, Myocet® and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma
Enrico Orciuolo, Gabriele Buda, Matteo Pelosini, Mario PetriniVolume:
148
Year:
2010
Language:
english
Pages:
3
DOI:
10.1111/j.1365-2141.2009.07998.x
File:
PDF, 169 KB
english, 2010